Literature DB >> 7848529

Developmental changes in the distribution of pro-opiomelanocortin and prolactin mRNA in the pituitary of the ovine fetus and lamb.

S G Matthews1, X Han, F Lu, J R Challis.   

Abstract

Ontogenic changes in pituitary pro-opiomelanocortin (POMC) mRNA and prolactin (PRL) mRNA were examined during gestation and early neonatal life using in situ hybridization histochemistry. Pituitaries were harvested from fetuses at days 60-80, 100-120, 135-140 and 142-143 of gestation and at term, and from lambs at days 1-7 and 30-60 of age and adults. POMC mRNA, present by day 60, rose during mid- and late gestation. Concurrently there was a change in corticotroph distribution, resulting in a relatively greater quantity of POMC mRNA at the base of the pars distalis. At term, there was a significant (P < 0.05) further elevation of POMC mRNA. POMC mRNA levels remained high in the newborn lamb but decreased in the adult. Cells in the pars intermedia expressed large amounts of POMC mRNA early in fetal life and this pattern persisted throughout gestation and into the neonatal period. Changes in the expression of the POMC gene correlated closely with the presence of immunoreactive (ir)ACTH in the pituitary; in fetuses the proportion of irACTH-positive cells rose to 10% of pars distalis cells by day 100 and did not change significantly thereafter. The lactotrophs contained PRL mRNA by day 60, and the quantity increased towards parturition (P < 0.05). PRL mRNA subsequently decreased in the neonate, but rose as the lamb matured. These results indicate that in the fetal pituitary: (1) the POMC gene is highly expressed during gestation in both the pars distalis and the pars intermedia, (2) changes in the amounts of POMC mRNA and PRL mRNA in the pars distalis correlate with the distribution of irACTH and irPRL respectively, and (3) POMC mRNA is distributed primarily in the inferior aspect of the pars distalis, and in this region its quantity is highest immediately prior to parturition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7848529     DOI: 10.1677/jme.0.0130175

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  7 in total

1.  Functional heterogeneity of corticotrophs in the anterior pituitary of the sheep fetus.

Authors:  T G Butler; J Schwartz; I C McMillen
Journal:  J Physiol       Date:  1999-05-01       Impact factor: 5.182

2.  Effects of cortisol and estradiol on pituitary expression of proopiomelanocortin, prohormone convertase-1, prohormone convertase-2, and glucocorticoid receptor mRNA in fetal sheep.

Authors:  A C Holloway; W L Whittle; J R Challis
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

3.  Hypothalamic input is required for development of normal numbers of thyrotrophs and gonadotrophs, but not other anterior pituitary cells in late gestation sheep.

Authors:  Eva Szarek; Kirsten Farrand; I Caroline McMillen; I Ross Young; Daniel Houghton; Jeffrey Schwartz
Journal:  J Physiol       Date:  2007-12-20       Impact factor: 5.182

4.  Effects of labor on pituitary expression of proopiomelanocortin, prohormone convertase (PC)-1, PC-2, and glucocorticoid receptor mRNA in fetal sheep.

Authors:  A C Holloway; S Gyomorey; J R Challis
Journal:  Endocrine       Date:  2000-08       Impact factor: 3.633

5.  CRH and AVP-induced changes in synthesis and release of ACTH from the ovine fetal pituitary in vitro: negative influences of cortisol.

Authors:  S G Matthews; J R Challis
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

6.  The effects of estradiol-17 beta infusion into fetal sheep in late gestation.

Authors:  S Wang; S G Matthews; T M Jeffray; M Y Stevens; K Yang; G L Hammond; J R Challis
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

7.  Molecular regulation of the hypothalamic-pituitary-adrenal axis in adult male guinea pigs after prenatal stress at different stages of gestation.

Authors:  Amita Kapoor; Jason Leen; Stephen G Matthews
Journal:  J Physiol       Date:  2008-07-17       Impact factor: 5.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.